Purple Book reference family · 351(a) biologic
peginterferon beta-1a (Plegridy)
peginterferon beta-1a is an FDA-licensed reference biologic from Biogen Inc..
351(a) biologicBLA 125499 Biogen Inc.
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
2014
Reference product
Originator biologic
351(a)BLA 125499
Plegridy peginterferon beta-1a
Biogen Inc.
View full reference-product record- Approved
- Marketing
- Rx
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Protection horizon
Reference approval
Approval date of the reference peginterferon beta-1a product.
12 yr 1 mo ago
peginterferon beta-1a: frequently asked questions
Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.
Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for peginterferon beta-1a.
Related FDA reference tools
- FDA Orange BookApproved drugs, generics, therapeutic-equivalence codes, patents, and exclusivity.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
